InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,284.00
(
0.36%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.31
(
0.99%
)
Bitcoin
61,425.78
(
1.03%
)
Post# of 30046
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

GetSeriousOK

Send PM Follow Ignore
Followers 37
Posts 7026
Boards Moderated 1
Alias Born 09/06/2014

GetSeriousOK

Re: dcspka post# 25538

Wednesday, 10/08/2014 5:41:01 PM

Wednesday, October 08, 2014 5:41:01 PM

Post# of 30046
Anyone who buys generic drugs knows:

When a patent expires, anyone can manufacture and sell the product.

Nobody will buy Radient or merge with Radient now to acquire DR-70 (onko-sure). If an entity is going to take over Radient or merge with Radient, it has to be for something other than DR-70.

I don't see what that could possibly be. Radient has no assets other than a patent on obsolete technology invented by Dr. Chang in the 1990's. That technology is worthless today. But don't take my word for that: Read the 2011 10K where Radient wrote it off as worthless.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up